LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 26.70 | 17.25 | 126 | 1466 | 0.0859 | 0.3637 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 26.70 | 17.25 | 1311 | 1466 | 0.8938 | 0.9653 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 28.67 | 17.25 | 1 | 1653 | 0.0006 | -0.3512 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 28.67 | 17.25 | 969 | 1653 | 0.5862 | 0.8441 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 28.67 | 17.25 | 175 | 1653 | 0.1059 | 0.4219 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 28.67 | 17.25 | 1411 | 1653 | 0.8535 | 0.9525 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 30.64 | 17.25 | 1 | 1887 | 0.0005 | -0.3433 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 30.64 | 17.25 | 1023 | 1887 | 0.5420 | 0.8271 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 30.64 | 17.25 | 252 | 1887 | 0.1335 | 0.4857 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 30.64 | 17.25 | 1497 | 1887 | 0.7931 | 0.9327 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 32.61 | 17.25 | 1 | 2136 | 0.0005 | -0.3361 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 32.61 | 17.25 | 1106 | 2136 | 0.5177 | 0.8193 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 32.61 | 17.25 | 294 | 2136 | 0.1376 | 0.5036 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 32.61 | 17.25 | 1596 | 2136 | 0.7471 | 0.9179 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 34.57 | 17.25 | 1 | 2523 | 0.0004 | -0.3270 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 34.57 | 17.25 | 1167 | 2523 | 0.4625 | 0.7967 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 34.57 | 17.25 | 462 | 2523 | 0.1831 | 0.5795 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 34.57 | 17.25 | 1713 | 2523 | 0.6789 | 0.8952 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 36.54 | 17.25 | 1 | 2679 | 0.0004 | -0.3238 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 36.54 | 17.25 | 1245 | 2679 | 0.4646 | 0.8001 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 36.54 | 17.25 | 498 | 2679 | 0.1858 | 0.5872 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 36.54 | 17.25 | 1802 | 2679 | 0.6724 | 0.8939 | MN20160310_N02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 38.51 | 17.25 | 1 | 2906 | 0.0003 | -0.3196 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 38.51 | 17.25 | 1328 | 2906 | 0.4570 | 0.7991 | MN20160310_N02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 38.51 | 17.25 | 557 | 2906 | 0.1917 | 0.5997 | MN20160310_N02 | K11 |